HB 2182 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

PRINTER'S NO.   2836

                     THE GENERAL ASSEMBLY OF PENNSYLVANIA



                         HOUSE BILL
                         No. 2182
                                               Session of
                                                 2026

     INTRODUCED BY PIELLI, MUNROE, McNEILL, HILL-EVANS, SANCHEZ,
        BRENNAN, D. WILLIAMS, O'MARA, GREEN, HANBIDGE, DALEY, CEPEDA-
        FREYTIZ AND BOROWSKI, JANUARY 30, 2026

     REFERRED TO COMMITTEE ON HEALTH, JANUARY 30, 2026


                                    AN ACT
 1   Amending the act of April 14, 1972 (P.L.233, No.64), entitled
 2      "An act relating to the manufacture, sale and possession of
 3      controlled substances, other drugs, devices and cosmetics;
 4      conferring powers on the courts and the secretary and
 5      Department of Health, and a newly created Pennsylvania Drug,
 6      Device and Cosmetic Board; establishing schedules of
 7      controlled substances; providing penalties; requiring
 8      registration of persons engaged in the drug trade and for the
 9      revocation or suspension of certain licenses and
10      registrations; and repealing an act," further providing for
11      drug overdose medication.
12      The General Assembly of the Commonwealth of Pennsylvania
13   hereby enacts as follows:
14      Section 1.    Section 13.8(a)(1) of the act of April 14, 1972
15   (P.L.233, No.64), known as The Controlled Substance, Drug,
16   Device and Cosmetic Act, is amended to read:
17      Section 13.8.    Drug Overdose Medication.--(a)     The
18   department, in carrying out its duties under 28 Pa. Code Ch.
19   1023 (relating to personnel), shall have the following duties:
20      (1)   Amend the prehospital practitioner scope of practice of
21   emergency medical services providers to include the
22   administration of an opioid antagonist, including naloxone and
1   nalmefene.
2      * * *
3      Section 2.   This act shall take effect in 60 days.




20260HB2182PN2836                 - 2 -